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1. Introduction 
Cardiac resynchronization therapy (CRT) with atriobiventricular pacing has been utilized 
for more than a decade for severe congestive heart failure associated with intraventricular 
dyssynchrony. The primary objective of CRT is to coordinate myocardial contraction with 
stimulation via right atrial (RA), right ventricular (RV) and left ventricular (LV) leads, using 
a biventricular pacemaker (CRT-P) or defibrillator (CRT-D). Although it provides both 
morbidity and mortality benefits in addition to medical therapy and implantable 
cardioverter-defibrillator, several issues remain unresolved, most importantly the high 
number of non-responder patients (up to 30%) and the technically challenging implantation. 
These are linked, as optimal lead position is essential for successful resynchronization. 
Atriobiventricular pacing is most commonly accomplished with transvenous placement of 
the system. Endocardial right atrial and right ventricular leads are conventional. The left 
ventricle is stimulated via a branch of the coronary sinus, performing epicardial stimulation. 
Unfavorable coronary sinus or vein anatomy, such as valves, tortuosity or focal stenosis may 
render left ventricular lead implantation very difficult. Even in the absence of these, there 
may be no appropriate vein in the area which would provide effective resynchronization. 
The average implantation time of CRT in high volume centers is under 2 hours, with a 
procedural success rate of 87%-96% (Alonso, 2009). Perioperative complications are seen in 
10% and the rate of late complications is 5.5% (Khan, 2009).  
Recent evidence suggests that LV lead position is crucial to ensure effective CRT. This 
chapter will review the indications for CRT, use of imaging modalities to facilitate targeted 
lead placement, perioperative issues and techniques shown to be useful in challenging cases. 
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2. Indications for CRT 
Most clinical CRT trials were performed in patients with advanced heart failure: LVEF 
≤35%, wide QRS, sinus rhythm, NYHA III-IV functional stage despite optimal medical 
treatment (COMPANION, CARE-HF, MIRACLE, MUSTIC SR etc.). Few studies included 
patients with less severe symptoms (MADIT CRT, REVERSE, RAFT) or who were in atrial 
fibrillation (MUSTIC-AF and partially RAFT). The guidelines for implantation were recently 
updated by the HFA and ESC (McMurray, 2012). (Figure 1) 
 
Figure 1. Indications for cardiac resynchronization therapy, Heart Failure Association and European 
Society of Cardiology, 2012 (McMurray, 2012). Stage IV heart failure patients should be “ambulatory” – 
pressor-dependent or acutely decompensated patients are generally not good candidates for CRT. HF: 
heart failure. CRT: cardiac resynchronization therapy. NYHA: New York Heart Association functional class. 
LVEF: left ventricular ejection fraction. LBBB: left bundle branch block. CRT-P: cardiac resynchronization with 
biventricular pacemaker. CRT-D: cardiac resynchronization with biventricular implantable cardioverter 
defibrillator. PM: pacemaker. AV: atrioventricular. Class: strength of indication (class I – implantation 
recommended, class IIa – implantation should be considered, class IIb – implantation may be considered). LOE: 
level of evidence (A: multiple randomized trials or meta-analysis, C: expert opinion)  
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3. Pre-implantation evaluation 
Patient evaluation prior to implantation should include assessment of functional stage, left 
ventricular ejection fraction and 12-lead ECG to determine whether the patient is a 
candidate for CRT. Potentially reversible factors contributing to heart failure and 
cardiomyopathy should be looked for and corrected (ischemia, hypertension, suboptimal 
medical management etc.). Co-morbidities limiting life expectancy or decreasing possible 
benefits of CRT should be identified (cardiac cachexia, advanced renal disease, frailty etc.) 
(Theuns, 2011). Advanced age alone is not a contraindication to CRT. History of arrhythmias 
and eligibility for ICD should be also assessed to guide device and lead selection. The 
patient should not be in a decompensated condition at the time of implantation. Heart 
failure medications must be utilized at maximally tolerated doses for at least 3 months prior 
to considering the patient as a candidate for CRT implantation. In the immediate pre-
implantation period, basic laboratory parameters should be checked and corrected as 
necessary to minimize surgical risks (complete blood cell count, electrolytes and kidney 
function, coagulation tests) (Epstein, 2008). A standardized evaluation of heart failure may 
help to assess response to CRT (serum BNP, 6 minute walking test). 
Echocardiography is the most common test performed to assess severity of left ventricular 
dysfunction. Right ventricular dysfunction may affect response to CRT and should also be 
evaluated (Burri, 2010). Although multiple echocardiographic measurements exist to 
evaluate intraventricular or interventricular mechanical dyssynchrony, so far these were not 
proven to be helpful to guide patient selection for CRT. Absence of echocardiographic 
dyssynchrony should not defer utilization of CRT if the patient would otherwise be a 
candidate, however, the risk of deterioration is higher in these cases (Mullens, 2009). 
Cardiac MRI with delayed enhancement imaging may be considered when the presence and 
location of myocardial scar is relevant and echocardiography is non-diagnostic (Bleeker, 
2006). 
4. Assessment of coronary vein anatomy 
Transvenous endovascular left ventricular lead placement is limited by the anatomic 
constraints of the coronary veins. Patients with history of thoracic irradiation or cardiac 
surgeries may be at high risk for unsuccessful left ventricular lead implantation. Imaging 
studies prior to implantation may help to determine if the patient is suitable for transvenous 
implantation. 
Coronary angiography is routinely performed during the workup of heart failure. Delayed 
images after contrast injection into the coronary arteries may outline the anatomy of the 
coronary sinus and its main branches. A major advantage of this method is that it does not 
provide any additional burden to the patient. The position of the orifice, the angle of the 
proximal CS, tortuousity and diameter of the vein are valuable clues for the selection of 
target vessel and the implantation approach. Most useful projections are anteroposterior 
and left anterior oblique, as these are common working views during CRT implantation. 
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Although the image quality is rarely good enough to assess terminal branches of the CS, the 
data obtained during coronary angiography may be used to identify fluoroscopic markers 
for CS cannulation as the ostium is almost always visualized. Another limitation is that this 
approach provides only two dimensional data (Kovacs, 2004) (Figure 2). 
 
Figure 2. Evaluation of coronary vein anatomy during cardiac catheterization. The venous phase after 
contrast injection into the left coronary artery shows the coronary sinus and its major branches. 
Although the smaller branches are not visualized, the images are helpful to localize the CS ostium, the 
angle of the CS and origin of its major branches. The images correlate with those obtained during 
retrograde CS angiography. 
Cardiac CT angiography provides detailed assessment of coronary arterial and venous 
anatomy, but requires x-ray radiation and contrast. Pre-implantation evaluation of the 
coronary venous anatomy can facilitate CRT, leading to decreased procedure time (Girsky, 
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2010 and Doganay, 2011). Area of latest mechanical activation may be correlated with 
echocardiographic images and veins in this region should be targeted for LV lead 
implantation – this approach correlates with improved acute response to CRT, however, no 
long term data available yet (Van de Veire, 2008). The phrenic nerve may also be visualized 
to identify high risk regions for inadvertent diaphragmatic stimulation (Matsumoto, 2007). 
Fusion of CT and fluoroscopic images may be of even greater benefit (Auricchio, 2009). 
Contrast allergy and advanced renal disease are contraindications for cardiac CT. 
Cardiac MRI can also be used to assess coronary veins. These images may be overlayed with 
other MRI data, such as scar distribution or area of latest activation (Duckett, 2011a; White, 
2010 and Kronborg, 2012). Imaging of scar burden improves prediction of response to CRT: 
in ischemic cardiomyopathy, less than 15% of total myocardium infarcted and absence of 
significant posterolateral scar is associated with better response (Bilchick, 2008 and Chalil, 
2007). Real time MRI-guided intubation of the coronary sinus is being investigated (Neizel, 
2010). Cardiac MRI requires gadolinium-based contrast and is contraindicated in patients 
with advanced renal dysfunction. Previously implanted non-MRI compatible hardware may 
also limit its utilization. The scanning times are longer and image acquisition requires some 
patient cooperation, which may be poorly tolerated in severe heart failure. 
Although these advanced imaging modalities have improved both implantation success rate 
and responder rate in small studies, currently it is not known whether routine application in 
all patients undergoing CRT would be cost-efficient. In patients undergoing CRT, review of 
all existing relevant imaging data is recommended for implant strategy planning. Advanced 
modalities should be reserved for cases where difficult anatomy is anticipated or if the 
patient had an unsuccessful implantation attempt. If cardiac CT and MRI will be shown to 
predict and facilitate CRT in a cost-efficient manner, these modalities may potentially be 
implemented on a more routine basis in the future. 
5. Perioperative period 
The patient should be on a stable heart failure medication regimen for at least 3 months 
before CRT implantation. Vasopressor-dependent or significantly fluid 
overloaded/congested patients are not good candidates for the procedure. Following 
implantation, careful monitoring is required as occasionally significant diuresis is observed 
with initiation of CRT, leading to electrolyte imbalances. The dose of heart failure 
medications should be titrated as tolerated after recovery from the implantation procedure. 
Bradycardia may not be a limiting factor after CRT implantation when considering 
utilization of higher dose of beta-blockers. Hypotensive side effects of ACE inhibitors and 
other vasodilators may be less pronounced, however, individual responses vary 
significantly. The dose of diuretics should be decreased if significant improvement in 
volume status is observed with CRT, to avoid prerenal azotemia and hypotension. 
Almost all patients undergoing CRT implantation are on antiplatelet or anticoagulation 
therapy, which increases bleeding risks. Compared to untreated patients, the likelihood of 
bleeding complications is doubled in patients on aspirin and quadrupled with dual 
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antiplatelet therapy (1.6%, 3.9% and 7.2%, respectively) (Jamula, 2008). Antiplatelet 
medications for primary prevention can be safely discontinued for a period of 5–7 days prior 
to the implantation. Dual antiplatelet therapy following PCI should not be discontinued in 
patients high risk for subacute stent thrombosis (such as early after coronary stent 
implantation, with timing dependent on stent type) (Tompkins, 2011). Bridging 
anticoagulation with heparin is associated with higher bleeding risk (up to 20%), where 
short-term discontinuation of anticoagulation is not an option – in these cases, continuation 
of coumadin is recommended (Tompkins, 2010). Continuation of coumadin has a risk of 
postoperative pocket bleeding of 1.9–6.6% (Wiegand, 2004). 
After decades of debate, now there is evidence that perioperative antibiotic prophylaxis 
decreases risk of infectious complications. Although these complications are rare (generally 
<1%), their consequences are devastating, leading to significant morbidity, mortality and 
costs (Klug, 2007 and Da Costa, 1998). Iv. cephazolin administered immediately before the 
procedure reduced the risk of infection from 3.28% to 0.63% in a large randomized trial (de 
Oliveira, 2009). Although some implant centers continue antibiotic utilization after the 
implantation, there is no proven benefit for this approach. Data regarding antibiotic 
prophylaxis for non-transvenous CRT implantation is scarce – generally, cardiothoracic 
surgical guidelines should apply as the optimal duration and selection of antibiotics may be 
affected by the given surgical approach (Mertz, 2011; Edwards, 2006 and Engelman, 2006). 
Most interventional techniques may be safely utilized in the pacemaker laboratory. It is 
preferable that the physician attempting a complex implantation or a device upgrade is well 
trained and current in the appropriate interventional and surgical techniques, or a physician 
with this training is immediately available. In case lead extraction is planned, a hybrid 
operating room or prompt access to surgical backup is mandatory. The incidence of 
unsuccessful implantations is declining, which is partly due to the advances in lead 
technology and implanting tools, however, interventional cardiology techniques have also 
been increasingly utilized with excellent efficacy and safety records. Minimally invasive 
surgical options are rapidly evolving and should be considered in case transvenous 
implantation is not feasible. 
Most common perioperative complications are failure to implant the LV lead, pocket 
hematoma, hemothorax or pneumothorax, CS dissection, cardiac perforation or tamponade, 
extracardiac stimulation, complete heart block, LV lead dislodgement, exacerbation of HF, 
acute renal failure, and death. Overall perioperative complication rates range from 4% in 
more recent trials to 28% in earlier CRT trials (Leon, 2005 and Linde, 2008). 
6. Targeting LV lead placement 
There is considerable variability in the ventricular activation pattern and distribution of 
mechanical dyssynchrony even in the LBBB population, and consequently inter-individual 
variability in the most optimal pacing site (Auricchio, 2004 and Derval, 2010). In addition, a 
significant number of patients don’t even have typical LBBB. Lead placement via 
endocardial and surgical epicardial approach may have more potential for individualized 
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targeted pacing. Targeting methods include those assessing electrical, mechanical and 
anatomic parameters, but there is no consensus yet regarding the best method to improve 
long term outcomes (Ansalone, 2002; Merchant, 2010; Gold, 2011 and Ypenburg, 2008). 
Apically positioned LV lead location is associated with a worse clinical outcome in the 
REVERSE and MADIT-CRT trials (Thebault, 2012 and Singh, 2011). The COMPANION and 
MADIT-CRT studies showed a comparable response between lateral, anterior or posterior 
LV lead locations, while patients in REVERSE benefited from a lateral lead location (Saxon, 
2009). Imaging may help to select specific sites for left ventricular pacing based on 
anticipated optimization of electromechanical effects (Toumoux, 2010). Echocardiography 
(tissue Doppler or tissue synchronization imaging) may identify LV sites with marked 
mechanical delay (Cannesson, 2006 and Murphy, 2006). Pacing these sites may result in 
greater ventricular remodeling and improved clinical outcomes. Currently there is not 
enough data supporting the role of acute hemodynamic measurements during implantation 
to target lead implantation (Duckett, 2011b).  
Multisite ventricular stimulation (more than one LV lead) may provide even greater benefits 
with more homogenous ventricular activation. More clinical data will be needed to evaluate 
whether it is superior to biventricular stimulation. 
7. Transvenous CRT implantation and reinterventions 
The standard approach to CRT is to implant three endovascular leads for cardiac 
stimulation: endocardial RV and RA leads, and an epicardial LV lead into a coronary vein 
through the CS. Transvenous implantation should be the preferred way for CRT as most 
evidence is with this approach. The standard transvenous approach has significant 
drawbacks as it is dependent on the highly variable venous anatomy. Main reasons of failed 
LV lead implantations are inability to cannulate the CS due to RA dilatation or prominent 
Thebesian valve, diminutive CS, severe kinking of the vein or venous valve in the CS. Even 
with successful lead placement, unstable position, high pacing threshold or phrenic nerve 
stimulation may hinder effective delivery of LV pacing. Implantation success rate is above 
90% in experienced centers, most failures are due to unsuccessful placement of the LV lead. 
In case of an unsuccessful procedure, repeat transvenous procedure with a more 
experienced operator or with interventional backup is recommended, if the venous anatomy 
seems to be suitable for implantation. In unsuitable cases, alternative approaches (surgical 
epicardial, transseptal endocardial) should be considered. 
The EHRA and HRS has recently published guidelines for recommended approach for 
transvenous CRT implantation (Daubert, 2012). Implantation should be performed from the 
left subclavian vein system, unless preexisting pathology (venous occlusion, infection) 
makes this approach unfeasible. The right ventricular lead should be placed first as it is less 
likely to dislodge during manipulation of other leads and provides information about the 
position of the tricuspid valve and right atrial size. 
 
Current Issues and Recent Advances in Pacemaker Therapy 20 
New guidelines emphasize the role of cardiac resynchronization therapy in subgroups of 
patients who already have conventional pacemakers, to avoid pacing-induced 
dyssynchrony and remodeling. Upgrading an existing device may pose difficulties due to 
the necessity to operate in a previously scarred area and the presence of previously 
implanted leads in the venous system. The perioperative risks in these patients are 
significantly higher: the 6-month major complication rate was 18.7% in the REPLACE 
registry in patients undergoing upgrade to a CRT device with addition of a new endocardial 
LV lead to the existing leads (Poole, 2010). The risk of subclavian vein thrombosis is related 
to the number of leads implanted, among recipients of CRT devices severe obstruction or 
occlusion can be observed in 30% (Bulur, 2010). Subclavian venography with injection 
through the upper extremity veins is a simple and effective technique to evaluate venous 
anatomy prior to an upgrade or lead revision. Venoplasty may be performed if ipsilateral 
implantation is favored (Worley, 2011). 
Extraction of non-used leads during an upgrade or revision has to be considered as the risk 
of long-term complications from abandoned leads is not negligible and correlates with the 
number of leads implanted and the number of prior procedures performed (Diemberger, 
2011). Implantation via the jugular or contralateral subclavian vein, with subcutaneous 
tunneling is required if the anatomy does not permit ipsilateral addition of a new lead. 
Although primary transvenous device implantations are routinely performed using 
conscious sedation without much patient discomfort, deep sedation or general anesthesia 
may be required for lead tunneling (Fox, 2007). In case lead extraction has to be performed 
prior to the upgrade, general anesthesia, invasive monitoring and availability of immediate 
surgical backup is recommended (Kratz, 2010). 
For CS cannulation, a wide array of sheaths are available. The ostium may be probed with a 
standard angiographic soft-tip wire, an angiographic catheter (such as Amplatz) may be 
inserted into the sheath to adjust its distal curve. Alternatively, a steerable CS EP catheter 
may also be used for mapping, individual practices vary significantly. Mapping with stiff 
catheters should be performed very cautiously as after overcoming any resistance from the 
Thebesian valve, the catheter may advance to the CS at an oblique angle, dissecting it, 
rendering continuation of the implantation procedure extremely difficult. This is most 
commonly encountered during insertion or advancement of the occlusion balloon catheter, 
as it has a relatively stiff distal portion. Transesophageal echocardiography may facilitate CS 
cannulation when traditional methods have proven ineffective (Bashir, 2003). In difficult 
cases intracardiac echocardiography may be more tolerable in patients under conscious 
sedation (Shalaby, 2005). 
Cannulation of the CS is followed by coronary sinus angiography using an occluder balloon. 
Fluoroscopic acquisition should allow time to image late filling terminal branches, due to 
collateral flow. Some centers perform a single venography image, however, two orthogonal 
views (RAO and LAO) are preferred for better visualization of 3 dimensional anatomy. A 
minority of centers perform rotational venography, which may provide more detailed 
information (Blendea, 2007). The location and takeoff of the ostium may vary considerably, 
can be distorted by right atrial enlargement or prior surgery. Distally in the CS, the valve of 
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Vieussens (typically 3-5 cm from the ostium) may hinder cannulation of the distal vessel 
(Ho, 2004). 
LV pacing leads may be implanted over a guidewire or directly. The guidewire may help to 
achieve more distal position by providing a rail when advancing the lead in a tortuous vein. 
Care should be taken to place the preformed fixation mechanism (curves, spiral or tags) 
with adequate distal penetration, to have a large area of contact with the vein wall (Hansky, 
2002). Most current leads are at least bipolar with size and flexibility similar to previous 
unipolar leads. The advantage of multiple electrodes is the possibility of electrical 
“repositioning” when high pacing threshold or phrenic nerve stimulation is encountered 
(Gurevitz, 2005 and Forleo, 2011). (Figure 3) 
 
Figure 3. A quadripolar CS lead allows multiple pacing configurations, providing options to avoid 
phrenic nerve stimulation or sites with high threshold. It also enables a more stable distal lead position, 
while still allowing pacing on the proximal electrodes if desired.  
If the vein is tortuous, a stiffer wire or buddy wire may be used with caution, as the wall 
thickness and tear resistance of coronary veins is much less compared to coronary arteries. 
In case severe tortuosity or kinking of the vein does not allow adequate force transition to 
advance the lead, use of telescopic guides may be considered (Russo, 2009). Inflated 
venogram (occluder) and coronary balloons can also be used as anchors to facilitate CS 
cannulation and left ventricular lead placement and help to recover lost CS and target vein 
access (Worley, 2009). 
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In case the target vein is stenotic, balloon angioplasty may be attempted.  Although the 
pathophysiological basis for coronary artery stenoses and coronary sinus/vein abnormalities 
are different, in most cases these obstacles can be overcome with the use of conventional 
interventional cardiology techniques. The required instrumentation is the same as for 
coronary artery angioplasties. In the majority of cases with a focal stenosis or valve, balloon 
angioplasty is a safe method to facilitate passage of the lead. In selected cases coronary 
atherectomy or stent implantation may be required (Soga, 2007). Angioplasty may also be 
used as a rescue when dissection of the coronary sinus or the target vein is observed during 
implantation, which would otherwise prohibit further attempts for lead placement (Bosa, 
2008 and Gutleben, 2008). In case of unfavorable coronary vein anatomy in the target area, 
dilatation and use of collateral veins may be considered (Abben, 2010). Complications from 
venoplasty are rare, however, venous rupture has been reported (Worley, 2008). With access 
to these techniques, implantation success rate may be as high as 99%: a retrospective single 
center analysis showed that 3.5% of patients required venoplasty for LV implantation (of 
these, 77% coronary vein, 13% subclavian vein, 10% valvular structures within the CS or a 
Marshall vein). The required inflation pressures for ring-like structures were high (16 ±3 
atm), complications were rare. Mostly short balloons with 3 mm diameter were used 
(Luedorff, 2008). The presence of a persistent left superior vena cava may prohibit successful 
CRT implantation due to severely dilated CS and distorted anatomy, however, successful 
use of angioplasty in this case was reported (Cagin, 2010). 
High pacing threshold or phrenic nerve stimulation may require repositioning of the lead 
from a stable to a less optimal position, where its fixation mechanism may not be as 
effective. In these cases, a coronary stent implanted near the distal end of the lead may 
stabilize the new position. A large single center study of 312 patients treated with stent 
implantation showed that the method was safe and effective in long term to prevent lead 
dislocation. 95% of patients had stenting due to intraoperative lead instability or phrenic 
nerve stimulation, while 5% required it due to previous lead disclocation. The bare metal 
stents were implanted 5-35 mm proximal to the most proximal electrode (unipolar and 
bipolar LV leads). There was no evidence of mechanical damage to the lead or CS 
perforation. During the follow-up of average 28.4 months, a significant increase in the left 
ventricular pacing threshold was found in four cases and reoperation was necessary in two 
patients (0.6%). Phrenic nerve stimulation was observed in 18 instances, and closed 
repositioning with an ablation catheter was performed in seven cases. In three cases the 
leads were extracted without complication after 3-49 months (infection, heart transplant) 
(Geller, 2011). (Figure 4) 
Coronary sinus dissection is a rare complication of LV lead placement. It may be recognized 
as inability to pass instruments though a previously accessible area, and pooling of contrast 
after angiography. Although complete perforation is even less common and the pressure in 
the CS is low, cardiac tamponade may occasionally develop. If the dissection is small, it may 
be possible to finish the implantation, although balloon angioplasty or stenting of the 
dissected segment may be necessary. In these cases, patients need to be monitored after the 
implantation, however, the exact duration that is required before a safe discharge is 
unknown (Figure 5). 
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Figure 4. Phrenic nerve stimulation was encountered in the distal lateral vein. In a more proximal 
position, the pacing threshold was acceptable with no diaphragmatic stimulation, however, the lead 
position was unstable. A bare metal coronary stent was implanted just proximal to the proximal 
electrode, after which the lead position stabilized. 
 
Figure 5. Complicated CS anatomy may prohibit transvenous lead implantation even with extensive 
use of interventional techniques. The targeted lateral vein has a narrowed proximal segment with a 
kink, which did not allow lead advancement (a). After passing a coronary guidewire, a bare metal stent 
was deposited into this region (b). Although the guidewire easily passed through this area, lead 
advancement was still not feasible, the stent is clearly visible (c). Selective venography shows dissection 
proximal to the stent (d). Even after multiple attempts with balloon angioplasty in this area, lead 
advancement was still not possible (e). After multiple attempts with a selective guide and buddy wire, 
repeat venography shows dissection of CS with distal occlusion and staining, at this point the 
procedure was aborted (f). No significant pericardial effusion or further sequelae were noted. 
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Epicardial left ventricular stimulation poses a unique challenge as the electrode position has 
to be stable to provide effective cardiac resynchronization with low energy output, while 
avoiding phrenic nerve stimulation. The coronary veins lack trabeculation and the thin wall 
prohibits the use of conventional screw-in active fixation leads. The majority of coronary 
sinus leads are passive fixation, which try to maintain stability with pre-shaped tips. 
Recently, built-in active lead fixation mechanisms became available. Up to 7% of 
transvenously placed LV leads may require revision (Borleffs, 2008) over long-term follow 
up (2 years). One third of the interventions are required more than 6 months after the 
implantation. A dislodged coronary sinus lead can be the source of multiple complications, 
such as inadvertent stimulation of extracardiac structures, arrhythmia or perforation, and 
loss of effective cardiac resynchronization. Repositioning most of the time requires access to 
the lead via a device pocket revision. As open revision carries a higher risk of system 
infection, minimally invasive procedures should be considered when appropriate. In some 
cases, the dislocation may be resolved by catheter-based techniques. In each case, an attempt 
has to be made to provide a more stable final lead position. A transfemoral approach was 
effective for the retraction of the LV lead from distal dislocation in a single center case series, 
where distal dislocation of the electrode lead to intolerable phrenic nerve stimulation 
(Szilagyi, 2008). The CS was cannulated with an Amplatz catheter, then a coronary stent was 
introduced over a guidewire besides the lead into the side branch in 7 patients or in 2 
patients, into the CS. A steerable ablation catheter was looped around the LV lead in the 
atrium with bent tip and was drawn backwards together. The stent was then inflated to 
stabilize the lead tip in a new position. During follow-up of median 7.7 months, stable 
pacing thresholds and impedances were measured; transient and avoidable phrenic nerve 
stimulation was present in only one patient. There were no procedural complications or 
infections. 
Stabilizing the lead position with retained stylets is not recommended due to high risk of 
late lead failure (Nagele, 2007). With active fixation of the CS leads, lead extraction may be 
an issue if the device has to be explanted. In the above mentioned case series, the few leads 
that had to be explanted and were previously stabilized with stent implantation, came out 
with manual traction most of the time, however, more data will be needed to assess if active 
anchoring of LV leads into the coronary veins poses any long-term risk.  
8. Transseptal endocardial left ventricular pacing 
Transseptal approach through the interatrial septum has been used for multiple 
interventional and electrophysiological procedures for decades. It is a relatively safe 
procedure in experienced hands, however, the facility should be prepared to address 
potential complications (mainly pericardiocentesis and emergent periocardiotomy). Using 
the transseptal approach, a conventional endocardial PM lead may be implanted into the LV 
cavity for endocardial stimulation. The thromboembolic risks are not negligible and these 
patient require long term anticoagulation. Mitral valve damage and endocarditis are rare, 
but serious compliations. 
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The transseptal implantation begins with a standard transseptal puncture via the femoral 
vein (van Gelder, 2007). After the successful puncture, full anticoagulation with iv. heparin 
is initiated. A 0.035-inch guidewire is inserted into one of the pulmonary veins and then the 
dilator and the sheath is removed. The puncture site is dilated with a 6-8 mm balloon. A 
steerable EP catheter is advanced from the subclavian area towards the interatrial septum, 
then into the left ventricle after deflating the balloon. A sheath is then advanced into the LA 
over the EP catheter. The endocardial surface of the LV may be mapped with the EP catheter 
to localize a site most suitable for lead implantation, then a standard endocardial bipolar 
pacemaker lead is implanted. Using a modified technique, electroanatomical mapping may 
be used to precisely identify the area of latest activation in the LV (Kutyifa, 2012). 
The main disadvantage of this technique is the unknown long term thromboembolic risk, 
which may be similar to a mechanical valve, with INR goals in the higher range (3-4). Over 
an average of 85 month follow up of 6 patients in a case series, one patient had LV lead 
dislodgment at 3 months requiring reintervention. One patient had a transient ischemic 
attack, when anticoagulation was accidentally interrupted (Pasquie, 2007). The need to start 
full dose anticoagulation immediately after the implantation increases the risk of 
periprocedural bleeding complications. 
This technique is a feasible and safe second option with a benefit of endocardial pacing site 
and implantation procedure with no more burden to the patient than conventional 
transvenous CRT implantation. Main disadvantage is the need for long term 
anticoagulation. Patients who are ineligible for surgical epicardial implantation and have no 
contraindications for lifelong oral anticoagulation can be selected for this approach. 
Biventricular pacing with endocardial stimulation may provide more homogenous 
intraventricular resynchronization than with epicardial stimulation, and is associated with 
better LV filling and systolic performance (Garrigue, 2001). 
9. Surgical epicardial LV lead placement 
In early cases of CRT, the LV lead was surgically placed via thoracotomy. This approach 
was associated with considerable morbidity, requiring general anesthesia and longer 
recovery time. Long term electrical stability of surgically placed electrodes is inferior when 
compared to transvenous leads (Lau, 2009). Major advantage of the surgical implantation is 
that it is not constrained by the venous anatomy and the latest contracting segment may be 
visually identified. Phrenic nerve stimulation may also be more easily avoided and there is 
no need for fluoroscopy. As transvenous implantation has a high success rate with excellent 
long-term stability, surgical implantation should not be considered are first line therapy. 
The risk of failed transvenous implant is higher in patients with prior cardiac surgeries 
(however, this also increases the risk of consecutive sternotomy/thoracotomy). In patients 
eligible for CRT, undergoing cardiothoracic surgical procedure, implantation of epicardial 
LV lead may be considered, which may be tunneled to the planned PM/ICD generator site. 
Surgical implantation may also be preferred in patients with complex congential heart 
disease, where the venous anatomy may interfere with the transvenous approach. 
 
Current Issues and Recent Advances in Pacemaker Therapy 26 
Usually, there is no need for full left thoracotomy for epicardial LV lead implantation as 
minimal thoracotomy provides adequate window for the procedure. The surgery is 
performed using single-lung ventilation on a beating heart. Transeosophageal 
echocardiography (TEE) control is needed throughout the procedure. A 3 to 5 cm incision is 
made over the 4th or 5th intercostal space anterior to the midaxillary line. The lung is 
pushed back and the pericardium is opened anterior to the phrenic nerve. The left ventricle 
is mapped for optimal pacing site and an epicardial lead placement device is used to attach 
the electrode (unipolar or bipolar) (Mair, 2005). The leads are tunneled to the PM/ICD 
generator site, usually in the left infraclavicular region. Short-term chest drainage is 
required postoperatively. A recent investigation described this technique as a safe and 
acceptable option, with benefits comparable to transvenous CRT: in 33 patients, functional 
and echocardiographic parameters showed similar improvement, however, with a delayed 
onset of peak VO2 improvement (Patwala, 2009). 
Instead of minimal thoracotomy, video assisted thoracoscopy may be used for lead 
placement. It uses two incisions for the ports in the 4th or 5th intercostal space along the 
anterior and midaxillary line. General anaesthesia and single lung ventilation enables the 
deflation of the left lung. The camera and the manipulating instruments are inserted 
through the ports, the pericardium is opened laterally to the phrenic nerve under visual 
control, then the epicardial lead is screwed into the lateral wall of the LV. The lead is passed 
through the medial incision and then tunneled subcutaneously to the generator site. The 
procedure is well tolerated, it has minimal postoperative recovery and very good cosmetic 
results. In a series of 15 patients, who previously failed transvenous implantation, mean 
skin-to-skin operating time was 55±16 min, no conversion to thoracotomy was necessary. All 
patients were extubated in the operating room and remained in the intensive care unit for 
less than 24h. Chest tubes were removed after a mean of 1.6±0.5 days and the patients were 
discharged after a mean of 4±1.3 days. Intraoperative and postoperative pacing thresholds at 
1 and 7 months were satisfactory in all cases and there was no lead dislocation. All but two 
patients had an improvement of their NYHA function class. There was neither surgical 
morbidity nor mortality (Gabor, 2005). 
Endoscopic robotic surgery is rapidly evolving and has been investigated for CRT. This 
technique also needs general anesthesia, single lung intubation and TEE. The left and right 
arms for the DaVinci system are placed in the 5th and 9th intercostal space. The pericardium 
is opened posterior to the phrenic nerve and the region of the obtuse marginal is identified 
to find the latest activating area with a temporary pacing electrode, the procedure is similar 
to the endoscopic approach. The patient is extubated immediately after the procedure and 
there is no need for a chest tube. Patients are usually discharged on the first postoperative 
day. Follow-up results of 42 patients showed a procedure time on the plateau of the learning 
curve of 45±13 minutes, with a responder rate of 81% and 70% at 3 and 6 month follow up. 
Three patients experienced loss of LV capture at 1, 9, and 14 months (a second lead, which 
was simultaneously implanted with the first one and also tunneled to the generator site had 
to be activated in these patients) (Joshi, 2005). With growing experience and availability of 
surgical robotic system, this method may gain more widespread utilization. 
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10. Transapical endocardial lead implantation 
This technique combines the minimally invasive surgical approach with the advantages of 
endocardial pacing. This may be the only option for patients with extensive epicardial 
adhesions prohibiting access to the pericardial space (Kassai, 2008). After induction of 
general anaesthesia and selective bronchial intubation, the LV apex is localized with 
transthoracic echocardiography, then a small left thoracotomy is performed. The apex of the 
left ventricle is punctured and an active fixation lead is inserted into the cavity, using 
Seldinger technique. The bleeding is controlled with purse-string sutures. The lead is guided 
into its final position with a guide, using fluoroscopy. As transapical endocardial lead 
implantation does not involve the mitral valve, the risk of mitral valve endocarditis is 
reduced. The lead is subcutaneously tunneled to the infraclavicular pocket to be connected 
to the generator. Long term anticoagulation is required, similar to patients with transseptal 
endocardial leads. Advantages of this technique are the accessibility of the endocardial 
segments without limitations of the CS anatomy and absence of phrenic nerve stimulation 
(Kassai, 2009). 
11. Conclusion 
Transvenous implantation of CRT systems is the preferred way as it poses the least risk for 
the patient, has excellent long term results and is supported by large amount of evidence 
from clinical trials. Familiarity with interventional angioplasty methods may facilitate the 
implant procedure. Although newer left ventricular leads have better maneuverability and 
improved fixation mechanisms, interventional techniques are useful adjuncts if difficult 
anatomy is encountered. In case of unsuitable anatomy of failed implantation, minimally 
invasive surgical procedures should be considered for LV lead placement.  
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